Coated or chewable Aspirin and a hybrid air pollution mitigation strategy in patients with atherosclerotic disease: Rationale and Design of the COATED-AIR Randomized Trial.

Bikdeli B, Talasaz AH, Bakhshandeh H, Hassanvand MS, Kakavand H, Jamalkhani S, Rashedi S, Tayyebi S, Babaei M, Kohansal E, Ghoshouni H, Mohtasham Kia Y, Nikkhoo M, Mohebbi B, Aghakouchakzadeh M, Alipour-Parsa S, Elahifar A, Khalilipur E, Omidvar R, Mehrpooya M, Sezavar SH, Jimenez D, Jara Palomares L, Mazloomzadeh S, Hadavand N, Ansari Dogaheh M, Maleki M, Noohi F, Ortega-Paz L, Raikhelkar JK, Steg PG, Lopes RD, De Caterina R, Shishehbor MH, Laine L, Angiolillo DJ, Rajagopalan S, Kirtane AJ, Piazza G, Lip GYH, Mehran R, Krumholz HM, Ridker PM, Sadeghipour P, COATED-AIR investigators

Open source

DOI
10.1093/ehjcvp/pvag071
Published
2026 Sep 23
Container
European heart journal. Cardiovascular pharmacotherapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ehjcvp/pvag071,
  title = {Coated or chewable Aspirin and a hybrid air pollution mitigation strategy in patients with atherosclerotic disease: Rationale and Design of the COATED-AIR Randomized Trial.},
  author = {Bikdeli B and Talasaz AH and Bakhshandeh H and Hassanvand MS and Kakavand H and Jamalkhani S and Rashedi S and Tayyebi S and Babaei M and Kohansal E and Ghoshouni H and Mohtasham Kia Y and Nikkhoo M and Mohebbi B and Aghakouchakzadeh M and Alipour-Parsa S and Elahifar A and Khalilipur E and Omidvar R and Mehrpooya M and Sezavar SH and Jimenez D and Jara Palomares L and Mazloomzadeh S and Hadavand N and Ansari Dogaheh M and Maleki M and Noohi F and Ortega-Paz L and Raikhelkar JK and Steg PG and Lopes RD and De Caterina R and Shishehbor MH and Laine L and Angiolillo DJ and Rajagopalan S and Kirtane AJ and Piazza G and Lip GYH and Mehran R and Krumholz HM and Ridker PM and Sadeghipour P and COATED-AIR investigators},
  year = {2026},
  journal = {European heart journal. Cardiovascular pharmacotherapy},
  doi = {10.1093/ehjcvp/pvag071},
  url = {https://doi.org/10.1093/ehjcvp/pvag071}
}

RIS

TY  - JOUR
TI  - Coated or chewable Aspirin and a hybrid air pollution mitigation strategy in patients with atherosclerotic disease: Rationale and Design of the COATED-AIR Randomized Trial.
AU  - Bikdeli B
AU  - Talasaz AH
AU  - Bakhshandeh H
AU  - Hassanvand MS
AU  - Kakavand H
AU  - Jamalkhani S
AU  - Rashedi S
AU  - Tayyebi S
AU  - Babaei M
AU  - Kohansal E
AU  - Ghoshouni H
AU  - Mohtasham Kia Y
AU  - Nikkhoo M
AU  - Mohebbi B
AU  - Aghakouchakzadeh M
AU  - Alipour-Parsa S
AU  - Elahifar A
AU  - Khalilipur E
AU  - Omidvar R
AU  - Mehrpooya M
AU  - Sezavar SH
AU  - Jimenez D
AU  - Jara Palomares L
AU  - Mazloomzadeh S
AU  - Hadavand N
AU  - Ansari Dogaheh M
AU  - Maleki M
AU  - Noohi F
AU  - Ortega-Paz L
AU  - Raikhelkar JK
AU  - Steg PG
AU  - Lopes RD
AU  - De Caterina R
AU  - Shishehbor MH
AU  - Laine L
AU  - Angiolillo DJ
AU  - Rajagopalan S
AU  - Kirtane AJ
AU  - Piazza G
AU  - Lip GYH
AU  - Mehran R
AU  - Krumholz HM
AU  - Ridker PM
AU  - Sadeghipour P
AU  - COATED-AIR investigators
PY  - 2026
JO  - European heart journal. Cardiovascular pharmacotherapy
DO  - 10.1093/ehjcvp/pvag071
UR  - https://doi.org/10.1093/ehjcvp/pvag071
ER  - 

APA

B, B., AH, T., H, B., MS, H., H, K., S, J., S, R., S, T., M, B., E, K., H, G., Y, M. K., M, N., B, M., M, A., S, A., A, E., E, K., R, O., M, M., SH, S., D, J., L, J. P., S, M., N, H., M, A. D., M, M., F, N., L, O., JK, R., PG, S., RD, L., R, D. C., MH, S., L, L., DJ, A., S, R., AJ, K., G, P., GYH, L., R, M., HM, K., PM, R., P, S., & investigators, C. (2026). Coated or chewable Aspirin and a hybrid air pollution mitigation strategy in patients with atherosclerotic disease: Rationale and Design of the COATED-AIR Randomized Trial.. European heart journal. Cardiovascular pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvag071

Source records